Executives from leading AI companies — including OpenAI's Sam Altman, Anthropic's Dario Amodei and Google DeepMind's Demis Hassabis — have submitted a public letter to the U.S. Congress calling for mandatory screening and recordkeeping for orders of synthetic nucleic acids. Reported by the WSJ and others on June 3, 2026, the letter urges that companies selling synthetic DNA and RNA be legally required to screen customers and orders to detect and block dangerous sequences, and to retain records (details). The full text and the list of signatories are published on a dedicated site (full text).
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.